After the close last night, Centers for Medicare and Medicaid Services released the final rule for the Medicare Advantage Risk Adjustment Data Validation audits, JPMorgan analyst Lisa Gill tells investors in a research note. The analyst believes the rule is more favorable for managed care companies than some investors had feared, even without a fee for service adjuster. In the final rule, CMS determined that audits prior to 2018 would not be extrapolated to the entire population in each contract selected, the firm points out. It believes improvements in data collection in recent years should result in a lower error rate in more recent audits, and not extrapolating audits prior to 2018 is a net benefit to managed care companies. In addition, the dollar value impact is lower than had been speculated and with payments not starting in earnest until 2025, the industry has time to prepare, the analyst contends.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CNC:
- Centene completes divestiture of Magellan Specialty Health to Evolent Health
- CENTENE COMPLETES DIVESTITURE OF MAGELLAN SPECIALTY HEALTH
- Centene call volume above normal and directionally bullish
- Centene put volume heavy and directionally bearish
- Centene raises 2024 adjusted EPS floor to $7.15 from $7.00